Researchers at LMU Munich have developed the first human cell model to accurately mimic the adult brain's tau protein mutations linked to Alzheimer's and other dementias. The model overcomes ...

The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.

Researchers at LMU have developed a human cell model that replicates key mechanisms of neurodegenerative diseases—with ...

Most asset managers try to track the market. Through ARK Investment, Cathie Wood is trying to get ahead of the market’s best ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $56.42, moving +1.58% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 1.05% for the ...

To accelerate discovery, scientists from ATCC and the Broad Institute collaborated to engineer a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding ...

For the first time, a research team at the Leibniz Institute of Plant Genetics and Crop Plant Research (IPK) has succeeded in ...